You haven't searched anything yet.
About Aura:
At Aura, our mission is to develop a new class of oncology targeted therapies that deliver meaningful therapeutic benefit to a range of cancer indications with high unmet need in which we believe we can establish a new standard of care. We are driven by our passion and commitment to science and the patients battling cancer who are relying on us to pioneer these new therapies.
We are focusing the initial development of our VDC technology platform to treat tumors of high unmet need in ocular and urologic oncology. AU-011, our first VDC candidate, is being developed for the first line treatment of primary choroidal melanoma, a rare disease with no drugs approved. Beyond primary choroidal melanoma, we are developing AU-011 in additional ocular oncology indications, including choroidal metastases. Leveraging our VDCs’ broad tumor targeting capabilities, we also plan to initiate a clinical program in non-muscle invasive bladder cancer, or NMIBC, our first non-ophthalmic solid tumor indication.
Position Summary:
The (Sr) Associate Scientist will contribute to the execution of Analytical Development (AD) objectives towards meeting Aura Biosciences’ business goal and its efforts to develop safe and effective therapies using virus-like particle (VLP)-based technologies. This role is expected to spend >80% at the bench.
Responsibilities include but are not limited to:
Minimum Requirements:
Knowledge, Skills & Capabilities:
Education & Relevant Work Experience:
Full Time
$142k-174k (estimate)
04/29/2024
05/18/2024
aurabiosciences.com
Cambridge, MA
<25